Compare the Efficacy of Ipratropium Bromide with Salbutamol and Salbutamol Alone in Recurrent Wheezes in Children with Asthma Presenting to LRH, Peshawar

نویسندگان

چکیده

Objective: Evaluate the effectiveness of Ipratropium Bromide in combination with Salbutamol and alone for treatment recurrent wheezes children asthma who seek care at LRH, Peshawar. Methods: After approval from institution review board, this randomized controlled trial was performed Department Pediatrics, Peshawar, 7th January 2021 to July 2021. A total 128 patients met inclusion criteria were recruited Pediatrics LRH In Group A, 64 given addition Salbutamol, whereas B, alone. group subjected salbutamol 2.5 mg thrice a day plus ipratropium bromide 125 ug 8 hourly during exacerbation episode. Patients contacted three months later assess progress, outcomes recorded using custom-made proforma. Results: 21.9% between age 1-2 years, while 78.1% 3-5 years Age. Mean 4.56±1.357 both study groups. 0ver all there 70.3% male 29.7 % females. 27.3% duration disease 6 72.7% have more than months. Most participated weight 16-20 kg (30.5%), followed by 26.6% 30kg, 21.1% 21-25kg. 56.2% had family history asthma, 43.8% no asthma. wise distribution efficacy among analyzed as (Ipratropium Salbutamol) showed 45% decrease number wheezing episodes B (Salbutamol group) 51.5% Conclusion: Our research reveals that mild moderate attacks does not improve over use Keywords: Efficacy alone, Recurrent wheezes, Children

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Bronchodilator effects of clemastine, ipratropium, bromide, and salbutamol in preschool children with asthma.

The bronchodilator activity in nebulised salbutamol, ipratropium bromide, clemastine, and a placebo was studied in 14 asthmatic children aged between 3 and 5 years. Changes in lung function were monitored by measuring peak expiratory flow rate and total respiratory resistance using a modification of the forced oscillation technique. Ipratropium bromide produced a degree of bronchodilation simil...

متن کامل

Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.

BACKGROUND Patients admitted with acute exacerbation of chronic obstructive pulmonary disease (COPD) are often prescribed ipratropium bromide in combination with a beta 2 agonist such as salbutamol. Studies have not shown any benefit in adding ipratropium bromide to salbutamol in acute exacerbations of COPD, but these studies have only assessed patients for 60-90 minutes and short term studies ...

متن کامل

Nebulized salbutamol vs salbutamol and ipratropium combination in asthma.

OBJECTIVE To see the additional benefit of combined frequent nebulization with salbutamol and ipratropium bromide in acute attack of asthma with moderate severity. METHODS Fifty asthmatic children in the age range of 6-14 years were divided into two equal groups. Group I children were nebulized with three doses of Salbutamol alone (0.03 ml/kg/dose) and Group II children were given combined ne...

متن کامل

Salbutamol and ipratropium in acute asthma.

Thirty seven children with acute asthma were given nebulised ipratropium or placebo 30 minutes after their first dose of salbutamol and eight hourly thereafter. There were no significant differences between the two groups in clinical scores, peak expiratory flow rates, length of stay in hospital, or the need for oral steroids.

متن کامل

Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma.

BACKGROUND Routine addition of ipratropium bromide to beta-agonist therapy in acute asthma is of uncertain benefit. OBJECTIVE This study was carried out to evaluate: (1) whether nebulized ipratropium (0.5 mg) plus salbutamol (2.5 mg) (Combivent) confers additional bronchodilation over nebulized salbutamol (2.5 mg) alone in patients with acute asthma and (2) whether adjustment for prognostic i...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Pakistan Journal of Medical and Health Sciences

سال: 2023

ISSN: ['1996-7195']

DOI: https://doi.org/10.53350/pjmhs2023173357